NEWCASTLE BIOSCIENCE
Live / Allowed — First extension granted (statement of use) (as of 14 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 05 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99220577
- Mark type
- Word mark
- Filed
- 05 Jun 2025
- Published for opposition
- 09 Dec 2025
- Attorney of record
- JOSEPH IRA HIRSCH
Goods and services
- Class 005 — Pharmaceuticals: House mark for a line of pharmaceutical preparations used to treat infectious diseases, cancer, pain, inflammation, cardiovascular diseases, neurological diseases, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, sleep disorders, ophthalmologic diseases, reproductive conditions and disorders, and respiratory conditions
Owner
- Newcastle Bioscience,LLC, Naples, FL, US
- Newcastle Bioscience,LLC, Naples, FL, US
Prosecution history
- 14 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2026 — SOU EXTENSION 1 GRANTED
- 13 Jul 2026 — SOU EXTENSION 1 FILED
- 13 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Nov 2025 — EXAMINER'S AMENDMENT ENTERED
- 10 Nov 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Nov 2025 — EXAMINERS AMENDMENT E-MAILED
- 10 Nov 2025 — EXAMINERS AMENDMENT -WRITTEN
- 06 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Nov 2025 — NON-FINAL ACTION E-MAILED